Hint mode is switched on Switch off
For swift navigation between sections

Celadon Pharmaceuticals
LEI 213800YXCATORT475807

PDF download

Choose all Reset all
Download Cancel
Organization name
Celadon Pharmaceuticals Plc (formerly Summerway Capital Plc)
Country name
United Kingdom
Country of registration
United Kingdom
Industry
Other Financial Institutions
Public debt
-
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Get access Watch full tour

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Celadon Pharmaceuticals Plc (formerly Summerway Capital Plc) operates as an investment company. The Company invests in household and consumer goods sectors. Summerway Capital serves clients in the United Kingdom.

Awards

News

28/07/2025 Celadon Pharmaceuticals: Result of General Meeting
02/07/2025 Celadon Pharmaceuticals: Proposed Cancellation
01/07/2025 Celadon Pharmaceuticals: Result of AGM
30/06/2025 Celadon Pharmaceuticals: Funding and Operational Update, Delay in Results
06/06/2025 Celadon Pharmaceuticals: Funding Update, Notice of AGM
All organization news

Documentation

Stocks

Public debt by currencies

Show more Hide

Codes

  • LEI
    213800YXCATORT475807
  • SIC
    6799 INVESTORS, NEC
  • NACE
    *** ***
  • NAICS
    *** ***
Registration is required to get access.